Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 7/20 | 0.85 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.79 |
| ▸ | MEN1 | O00255 | 8/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.79 |
| ▸ | CYP1A1 | P04798 | 7/20 | 0.79 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.79 |
| ▸ | XDH | P47989 | 6/20 | 0.79 |
| ▸ | IPMK | Q8NFU5 | 4/20 | 0.79 |
| ▸ | IP6K2 | Q9UHH9 | 4/20 | 0.79 |
| ▸ | CA12 | O43570 | 4/20 | 0.79 |
| ▸ | PPARG | P37231 | 4/20 | 0.79 |
| ▸ | CA7 | P43166 | 4/20 | 0.79 |
| ▸ | CA2 | P00918 | 3/20 | 0.79 |
| ▸ | CA4 | P22748 | 3/20 | 0.79 |
| ▸ | MAOA | P21397 | 6/20 | 0.70 |
| ▸ | FTO | Q9C0B1 | 5/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.70 |
| ▸ | AKR1B1 | P15121 | 4/20 | 0.70 |
| ▸ | BCHE | P06276 | 4/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Syringetin SCHEMBL29929167 | 1.00 | ABCB1 (0.85) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Laricytrin SCHEMBL29929477 | 0.96 | ABCB1 (0.83) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Laricytrin SCHEMBL19213534 | 0.96 | ABCB1 (0.83) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| SCHEMBL19249162 | 0.92 | ABCB1 (0.78) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| SCHEMBL4034698 | 0.92 | ABCB1 (1.00) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| SCHEMBL30255771 | 0.92 | ABCB1 (1.00) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| SCHEMBL3452793 | 0.90 | ABCB1 (0.77) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| SCHEMBL4649105 | 0.90 | ABCB1 (0.70) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| Isorhamnetin SCHEMBL19235 | 0.88 | MEN1 (1.00) | ABCB1CYP1A2MEN1KMT2ACYP1A1 | |
| SCHEMBL7375699 | 0.88 | ABCB1 (0.68) | ABCB1CYP1A2MEN1KMT2ACYP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2023004029-A1 | COMPOSITION FOR PREVENTING TEETH STAINING | ONSTAD ANDREW (US) | 2023-01-26 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2020136240-A1 | POLYPHENOL-PEPTIDE CONJUGATES FOR NUCLEAR-TARGETED DELIVERY | Universität Wien (AT) | 2020-07-02 | — | — | WO | claimed |
| EP-3673920-A1 | POLYPHENOL-PEPTIDE CONJUGATES FOR NUCLEAR-TARGETED DELIVERY | Universität Wien (AT) | 2020-07-01 | — | — | EP | claimed |
| CN-106389406-B | A kind of application of blood sugar reducing function compound | 中国药科大学 | 2019-02-22 | — | — | CN | claimed |
| CN-107773557-A | The medicinal usage of syringetin | 上海华堇生物技术有限责任公司 | 2018-03-09 | — | — | CN | claimed |
| CN-106389406-A | Applications of blood glucose lowering compound | 中国药科大学 | 2017-02-15 | — | — | CN | claimed |
| US-20120208118-A1 | RESIN COMPOSITIONS AND PROCESSES | XEROX CORPORATION (US) | 2012-08-16 | — | — | US | claimed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| JP-2003504327-A | — | — | 2003-02-04 | — | — | JP | claimed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | claimed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | claimed |
| US-20260090573-A1 | REDUCED-SUGAR FRUIT JUICE AND FRUIT MUST | INNOVATIVE STRATEGIC DESIGN, LLC (US) | 2026-04-02 | — | — | US | disclosed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | ABCB1 719/4885CYP1A2 3865/4885MEN1 1711/4885 |
| US-20260090573-A1 | REDUCED-SUGAR FRUIT JUICE AND FRUIT MUST | KCNN2, KCNN1, PROC | ABCB1 3785/4885CYP1A2 4521/4885MEN1 946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.